ArticleScientific reports2023

Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models.

María Jimena Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.